Poltorak, Mateusz P.
Graef, Patricia
Tschulik, Claudia
Wagner, Michaela
Cletiu, Vlad
Dreher, Stefan
Borjan, Bojana
Fraessle, Simon P.
Effenberger, Manuel
Turk, Martin
Busch, Dirk H.
Plitzko, Juergen
Kugler, David G.
Ragan, Seamus
Schmidt, Thomas
Stemberger, Christian
Germeroth, Lothar
Funding for this research was provided by:
Juno Therapeutics
Article History
Received: 20 April 2020
Accepted: 5 October 2020
First Online: 20 October 2020
Competing interests
: M.P.P., P.G., C.T., M.W., V.C., B.B., S.D., T.S., D.H.B., M.E., S.P.F., C.S., and L.G. are currently employed by Juno Therapeutics GmbH A Bristol-Myers Squibb Company and own stock of Bristol-Myers Squibb. D.K. and S.R. are currently employed by Juno Therapeutics Inc. A Bristol-Myers Squibb Company and own stock of Bristol-Myers Squibb. L.G., T.S., P.G., M.P.P., and C.S. are listed as inventors on previously filed related patent applications.